Lex B.
- Country
- The Netherlands
- Department
- Cardiology
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Evaluation of Balcinrenone and Dapagliflozin on Cardiovascular Outcomes in Heart Failure Patients with Renal Impairment: A Phase III Randomized, Double-Blind Study
- Evaluation of Baxdrostat and Dapagliflozin on Chronic Kidney Disease Progression in Hypertensive Patients: A Randomized, Double-Blind, Active-Controlled Phase III Trial
Data & Insights
Has run more than one trial at 117 of 656 partner sites.
Specializations
Cardiovascular Medicine
This investigator specializes in treating patients with atrial fibrillation and related cardiovascular conditions, with particular emphasis on stroke prevention and managing systemic embolism risks.
- Cardiac Rhythm Management
- Anticoagulation Therapy
- Stroke Prevention Strategies
The research focus includes evaluating novel therapeutic approaches for patients with irregular heartbeat conditions.
Nephrology
The investigator conducts research in chronic kidney disease (CKD) treatment, particularly focusing on patients with concurrent hypertension. Their work examines innovative therapeutic combinations to slow CKD progression.
- Renal Function Management
- Blood Pressure Control
- Glomerular Filtration Assessment
Areas of interest include monitoring and improving estimated glomerular filtration rates in CKD patients.
Heart Failure Management
The investigator focuses on treating chronic heart failure patients, particularly those with concurrent kidney function impairment. Their expertise extends to studying cardiovascular mortality reduction strategies.
- Cardiovascular Event Prevention
- Heart Failure Hospitalization
- Combination Therapy Approaches
The research encompasses evaluating therapeutic interventions for complex cardiac patients with multiple comorbidities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.